Actemra
tocilizumab
- Strength
- 162 mg/.9mL
- Form
- Injection, Solution
- Class
- Interleukin-6 Receptor Antagonist
Genentech, Inc.
Not stocked by us — reference only
TYENNE
Tocilizumab-aazg
Listed by Fresenius Kabi USA, LLC
- Strength
- 162 mg/.9mL
- Form
- Injection, Solution
- Route
- Subcutaneous
- Class
- Interleukin-6 Receptor Antagonist
What it contains
- Tocilizumab 162 mg/.9mL
FDA record
| Dosage form | Injection, Solution |
|---|---|
| Route | Subcutaneous |
| Drug class | Interleukin-6 Receptor Antagonist |
| Approval route | BLA — biologic licence |
| NDC code | 65219-586 |
| FDA application | BLA761275 |
| RxNorm concept | 2686045 |
| Package sizes listed | 1 |
| Marketed since | July 2024 |
Other products containing Tocilizumab
See allSame active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
ACTEMRA
tocilizumab
- Strength
- 400 mg/20mL
- Form
- Injection, Solution, Concentrate
- Class
- Interleukin-6 Receptor Antagonist
Genentech, Inc.
Not stocked by us — reference only
ACTEMRA
tocilizumab
- Strength
- 80 mg/4mL
- Form
- Injection, Solution, Concentrate
- Class
- Interleukin-6 Receptor Antagonist
Genentech, Inc.
Not stocked by us — reference only
ACTEMRA
tocilizumab
- Strength
- 200 mg/10mL
- Form
- Injection, Solution, Concentrate
- Class
- Interleukin-6 Receptor Antagonist
Genentech, Inc.
Not stocked by us — reference only
Actemra ACTPen
tocilizumab
- Strength
- 162 mg/.9mL
- Form
- Injection, Solution
- Class
- Interleukin-6 Receptor Antagonist
Genentech, Inc.
Not stocked by us — reference only
AVTOZMA
tocilizumab
- Strength
- 80 mg/4mL
- Form
- Injection, Solution
- Class
- Interleukin-6 Receptor Antagonist
CELLTRION USA, Inc.
Not stocked by us — reference only
AVTOZMA
tocilizumab
- Strength
- 162 mg/.9mL
- Form
- Injection, Solution
- Class
- Interleukin-6 Receptor Antagonist
CELLTRION USA, Inc.
Not stocked by us — reference only
AVTOZMA
tocilizumab
- Strength
- 400 mg/20mL
- Form
- Injection, Solution
- Class
- Interleukin-6 Receptor Antagonist
CELLTRION USA, Inc.
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.